Using BLCA as an example, significant differential expression of PABPN1 was observed across various cancer stages, histological subtypes, patient sex, molecular subtypes, nodal metastasis status, and TP53 mutation status of BLCA (Figures 6D–I). Here, TP53 is linked to bladder transitional cell carcinoma.